Production (Stage)
ABVC BioPharma, Inc.
ABVC
$1.15
-$0.06-4.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 217.30K | 313.10K | 208.20K | 200.00K | 106.40K |
| Total Receivables | 537.10K | 1.16M | 1.22M | 1.27M | 899.90K |
| Inventory | 11.50K | -- | -- | -- | -- |
| Prepaid Expenses | 96.40K | 96.20K | 91.30K | 100.80K | 159.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 607.40K | 615.40K | 632.50K | 618.50K | 628.50K |
| Total Current Assets | 1.47M | 2.18M | 2.15M | 2.19M | 1.79M |
|
|
|||||
| Total Current Assets | 1.47M | 2.18M | 2.15M | 2.19M | 1.79M |
| Net Property, Plant & Equipment | 8.70M | 1.15M | 8.44M | 8.54M | 8.66M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.94M | 1.95M | 1.54M | 1.53M | 1.53M |
| Total Assets | 14.88M | 7.54M | 14.46M | 14.63M | 14.46M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 3.00M | 3.21M | 3.18M | 3.31M | 3.13M |
| Short-term Debt | 1.37M | 1.46M | 1.11M | 1.03M | 1.01M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.34M | 1.50M | 1.49M | 1.48M | 1.38M |
| Total Finance Division Other Current Liabilities | 1.02M | 391.90K | 532.10K | 739.20K | 1.12M |
| Total Other Current Liabilities | 1.02M | 391.90K | 532.10K | 739.20K | 1.12M |
| Total Current Liabilities | 6.73M | 6.56M | 6.32M | 6.55M | 6.63M |
|
|
|||||
| Total Current Liabilities | 6.73M | 6.56M | 6.32M | 6.55M | 6.63M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.37M | 1.46M | 1.11M | 1.03M | 1.01M |
| Capital Leases | 167.00K | 236.80K | 142.20K | 228.80K | 318.20K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 21.70K | 21.70K | 25.70K | 27.70K | 21.70K |
| Total Liabilities | 6.92M | 6.82M | 6.48M | 6.81M | 6.97M |
|
|
|||||
| Common Stock & APIC | 83.63M | 78.61M | 87.32M | 87.09M | 86.04M |
| Retained Earnings | -69.79M | -68.95M | -70.55M | -70.37M | -69.35M |
| Treasury Stock & Other | -8.43M | -8.43M | -8.41M | -8.44M | -8.89M |
| Total Common Equity | 5.40M | 1.23M | 8.36M | 8.29M | 7.79M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.40M | 1.23M | 8.36M | 8.29M | 7.79M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 2.55M | -502.20K | -379.10K | -465.20K | -305.10K |
| Total Equity | 7.96M | 724.00K | 7.98M | 7.83M | 7.49M |
|
|
|||||